Trials / Conditions / Non-GCB/ABC Diffuse Large B-Cell Lymphoma
Non-GCB/ABC Diffuse Large B-Cell Lymphoma
3 registered clinical trials studyying Non-GCB/ABC Diffuse Large B-Cell Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) NCT05319028 | Calithera Biosciences, Inc | Phase 2 |
| Unknown | Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL NCT04835870 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Unknown | Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL NCT04796857 | Huiqiang Huang | Phase 1 / Phase 2 |